Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Avastin
Pharma
AZ charts new but uncertain path for Imfinzi in liver cancer
The lack of a survival showing and a questionable contribution from AZ's Imfinzi complicate the company's path in locoregional liver cancer.
Angus Liu
Jan 19, 2024 10:00am
FDA signs off on Takeda's colorectal cancer drug Fruzaqla
Nov 9, 2023 10:54am
Merck's Keytruda mostly won out at ESMO, with one notable miss
Oct 24, 2023 9:05am
Roche blasts 'act of counterfeiting' for cancer drug in Pakistan
Sep 25, 2023 2:27pm
FDA rejects Outlook's Avastin reformulation for eye disease
Aug 30, 2023 11:30am
Patient deaths taint Roche's landmark adjuvant liver cancer data
Apr 16, 2023 11:00am